-
Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir for COVID-19 Among Individuals at High Risk: A Modeling Study
Birnie, E., Vergouwe, M., Appelman, B., Biemond, J. J., Heijmans, J. & on behalf of the TURN-COVID study group, 1 Apr 2025, In: Open Forum Infect. Dis.. 12, 4, ofaf187.Research output: Contribution to journal › Article* › Academic › peer-review
-
A Longitudinal Description of the Health-Related Quality of Life Among Individuals at High Risk After SARS-CoV-2 Infection: A Dutch Multicenter Observational Cohort
Vergouwe, M., Birnie, E., van Veelen, S., Biemond, J. J., Appelman, B., Peters-Sengers, H., de Bree, G. J. & behalf of the TURN-COVID Study Group, 1 Feb 2025, In: Open Forum Infect. Dis.. 12, 2Research output: Contribution to journal › Article* › Academic › peer-review
-
A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals
Vergouwe, M., Biemond, J. J., van der Straten, K., van Pul, L., Kerster, G., Claireaux, M., Burger, J. A., van Dort, K. A., Kootstra, N. A., Jonges, M., Welkers, M. R. A., TURN-COVID study group, Bomers, M. K. & van Ittersum, F. J., 15 Oct 2024, In: The Journal of infectious diseases. 230, 4, p. e860-e871Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
